Alzheimer's disease, a progressive neurodegenerative disorder, presents varying prognoses influenced by several factors. Age is a primary determinant, with risk increasing significantly after 65 years. Genetic predispositions, such as the APOE ε4 allele, elevate susceptibility. Lifestyle factors like cardiovascular health and education level also play roles; poor cardiovascular health can exacerbate cognitive decline, while higher education levels appear protective. Neuroimaging studies reveal brain atrophy patterns and amyloid-beta deposits, aiding in prognostication. Additionally, early symptom severity and the rate of cognitive decline are crucial indicators. Advances in biomarker research, including cerebrospinal fluid analyses and PET scans, offer promising tools for predicting disease progression. Understanding these multifaceted prognostic factors is crucial for improving diagnostic accuracy, developing targeted interventions, and ultimately enhancing outcomes for Alzheimer's patients.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China